🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07114185
Starting soon Observational

A Prospective Study of Discomfort Symptoms in Patients With Aortic Disease After Endovascular Intervention

NCT07114185 · tracked via the Priya Life Science China tracker
Sponsor
First Affiliated Hospital of Zhejiang University
Phase
Observational
Started
2026-01-01
Last updated
2025-08-11

Condition(s) studied

Aortic Aneurysm and Dissection

Study summary

The incidence and severity of post-procedural discomfort were evaluated in patients undergoing endovascular repair for aortic disease across six symptom-related dimensions: immobilization-related issues, puncture site discomfort, adhesive-induced skin reactions, post-stent implantation syndrome, impairment in self-care ability, and physical/psychological stress responses.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: 1. Diagnosed with thoracoabdominal aortic disease 2. Patients who underwent endovascular treatment of the thoracoabdominal aorta via the femoral artery approach Exclusion Criteria: 1. Aortic disease caused by infection 2. Aortic disease caused by trauma 3. Aortic disease treated by open abdominal surgery 4. Presence of systemic diseases uncontrollable by current medical standards (e.g., severe cardiac, pulmonary or hepatic dysfunction; advanced malignancy; cachexia; refractory severe coronary artery disease symptoms; coagulation disorders caused by genetic diseases, etc.) 5. Patients who have undergone endovascular aortic treatment via femoral artery access prior to this procedure due to other diseases (not related to the current aortic disease)

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
The first affiliated hospital of Zhejiang University Hangzhou Zhejiang

More First Affiliated Hospital of Zhejiang University trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07114185 on ClinicalTrials.gov ↗ ← All trials in China